RSS
LNAplus platform
Biopharma secures co-development agreement for novel cancer therapies
Biopharmaceutical company, Secarna Pharmaceuticals, has entered into a co-development agreement with research and development company, Firebrand Therapeutics, for novel cancer therapies. Read more